Bifogade filer
Kurs
-0,75%
Likviditet
1,06 MSEK
Prenumeration
Kalender
Tid* | ||
2026-02-10 | 08:30 | Bokslutskommuniké 2025 |
2025-10-23 | 08:30 | Kvartalsrapport 2025-Q3 |
2025-07-18 | 08:30 | Kvartalsrapport 2025-Q2 |
2025-05-08 | N/A | Årsstämma |
2025-05-07 | 08:30 | Kvartalsrapport 2025-Q1 |
2025-02-07 | 08:30 | Bokslutskommuniké 2024 |
2024-10-23 | - | Kvartalsrapport 2024-Q3 |
2024-07-18 | - | Kvartalsrapport 2024-Q2 |
2024-05-16 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2024-05-15 | - | Årsstämma |
2024-05-14 | - | Kvartalsrapport 2024-Q1 |
2024-02-08 | - | Bokslutskommuniké 2023 |
2023-10-27 | - | Kvartalsrapport 2023-Q3 |
2023-07-20 | - | Kvartalsrapport 2023-Q2 |
2023-05-08 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2023-05-05 | - | Årsstämma |
2023-05-05 | - | Kvartalsrapport 2023-Q1 |
2023-01-26 | - | Bokslutskommuniké 2022 |
2022-10-28 | - | Kvartalsrapport 2022-Q3 |
2022-07-21 | - | Kvartalsrapport 2022-Q2 |
2022-05-09 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2022-05-06 | - | Årsstämma |
2022-05-06 | - | Kvartalsrapport 2022-Q1 |
2022-01-27 | - | Bokslutskommuniké 2021 |
2021-10-28 | - | Kvartalsrapport 2021-Q3 |
2021-07-29 | - | Kvartalsrapport 2021-Q2 |
2021-05-10 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2021-05-07 | - | Årsstämma |
2021-05-07 | - | Kvartalsrapport 2021-Q1 |
2021-01-28 | - | Bokslutskommuniké 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-07-31 | - | Kvartalsrapport 2020-Q2 |
2020-05-11 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2020-05-08 | - | Årsstämma |
2020-05-06 | - | Kvartalsrapport 2020-Q1 |
2020-01-31 | - | Bokslutskommuniké 2019 |
2019-12-17 | - | Extra Bolagsstämma 2019 |
2019-10-25 | - | Kvartalsrapport 2019-Q3 |
2019-08-30 | - | Kvartalsrapport 2019-Q2 |
2019-05-09 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2019-05-08 | - | Årsstämma |
2019-05-08 | - | Kvartalsrapport 2019-Q1 |
2019-02-08 | - | Bokslutskommuniké 2018 |
2018-10-26 | - | Kvartalsrapport 2018-Q3 |
2018-08-17 | - | Kvartalsrapport 2018-Q2 |
2018-05-31 | - | Årsstämma |
2018-05-18 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2018-04-26 | - | Kvartalsrapport 2018-Q1 |
2018-01-31 | - | Bokslutskommuniké 2017 |
2017-10-27 | - | Kvartalsrapport 2017-Q3 |
2017-08-16 | - | Kvartalsrapport 2017-Q2 |
2017-05-02 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2017-04-28 | - | Årsstämma |
2017-04-28 | - | Kvartalsrapport 2017-Q1 |
2017-02-13 | - | Bokslutskommuniké 2016 |
2016-11-17 | - | Extra Bolagsstämma 2016 |
2016-11-14 | - | Kvartalsrapport 2016-Q3 |
2016-08-24 | - | Kvartalsrapport 2016-Q2 |
2016-05-09 | - | Kvartalsrapport 2016-Q1 |
2016-04-15 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2016-04-14 | - | Årsstämma |
2016-02-08 | - | Bokslutskommuniké 2015 |
2015-11-06 | - | Kvartalsrapport 2015-Q3 |
2015-08-14 | - | Kvartalsrapport 2015-Q2 |
2015-05-08 | - | Kvartalsrapport 2015-Q1 |
2015-04-17 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2015-04-16 | - | Årsstämma |
2015-01-30 | - | Bokslutskommuniké 2014 |
2014-11-07 | - | Kvartalsrapport 2014-Q3 |
2014-11-07 | - | Analytiker möte 2014 |
2014-08-15 | - | Kvartalsrapport 2014-Q2 |
2014-05-16 | - | Kvartalsrapport 2014-Q1 |
2014-04-17 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2014-04-16 | - | Årsstämma |
2014-02-17 | - | Bokslutskommuniké 2013 |
2013-11-28 | - | Kvartalsrapport 2013-Q3 |
2013-11-01 | - | Analytiker möte 2013 |
2013-10-30 | - | Extra Bolagsstämma 2013 |
2013-09-02 | - | 15-7 2013 |
2013-08-30 | - | Kvartalsrapport 2013-Q2 |
2013-06-03 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2013-05-31 | - | Årsstämma |
2013-05-29 | - | Kvartalsrapport 2013-Q1 |
2013-02-26 | - | Bokslutskommuniké 2012 |
2012-12-04 | - | Extra Bolagsstämma 2012 |
2012-11-28 | - | Kvartalsrapport 2012-Q3 |
2012-09-04 | - | Kvartalsrapport 2012-Q2 |
2012-06-04 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2012-06-01 | - | Årsstämma |
2012-05-24 | - | Kvartalsrapport 2012-Q1 |
2012-02-24 | - | Bokslutskommuniké 2011 |
2011-11-25 | - | Kvartalsrapport 2011-Q3 |
2011-08-26 | - | Kvartalsrapport 2011-Q2 |
2011-05-26 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2011-05-25 | - | Årsstämma |
2011-05-24 | - | Kvartalsrapport 2011-Q1 |
2011-02-11 | - | Bokslutskommuniké 2010 |
2010-06-02 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
2010-06-01 | - | Årsstämma |
2010-05-28 | - | Kvartalsrapport 2010-Q1 |
2009-11-27 | - | Kvartalsrapport 2009-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
C-RAD’s annual report for 2023 has today been published online in Swedish and English at the company’s website, https://c-rad.com/investors/financial-reports/
In the published annual report, C-RAD’s profit for 2023, has been charged with an additional
-10.5 MSEK as a consequence of the decision from the Supreme Court in February 2024. This amount is the company’s assessment based on the court ruling. The amount relates to compensation for all periods up to 31st of December 2023.
In accordance with the press release published on the 22nd of February 2024, the Supreme Court announced that it would not grant leave to appeal in the dispute between C-RAD and a former employee. This decision upholds the ruling of the Patent and Market Court of Appeal on 30th of June 2023. As a consequence of the Supreme Court’s decision, in the annual report for 2023, C-RAD has charged the Group’s profit for the year, as reported in the year-end report for 2023, with an additional -10.5 MSEK. See note 33 for how the various adjusting items have been accounted.
The auditor’s report is deviating from what is common, as a remark is stated by the auditor related to that social security taxes and value added taxes were not paid in due time on several occasions during the year in the parent company. C-RAD notes that the delays have not occurred by insufficient liquidity, but due to temporary deficiencies in the administrative routines. The latter have now been corrected to make sure that this should not be repeated, please refer to the Corporate governance report.
The annual report is available at www.c-rad.com and printed annual reports are available for shareholders and other stakeholders at the company’s office.
The annual report is published in accordance with the demands stated in European Single Electronic Format (ESEF). In accordance to the demands in ESEF, the annual report is mapped with XBRL-tags. ESEF-files can be downloaded at www.c-rad.com.
About C-RAD
C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.
C-RAD. Inspiring excellence in cancer treatment.
C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit http://www.c-rad.com
This information is information that C-RAD is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-04-23 16:35 CEST.